- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 209/88 - Separation of optical isomers
Patent holdings for IPC class C07C 209/88
Total number of patents in this class: 50
10-year publication summary
|
6
|
3
|
3
|
2
|
0
|
3
|
2
|
3
|
0
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21303 |
6 |
| Sumitomo Chemical Company, Limited | 9016 |
5 |
| Celgene Corporation | 1410 |
5 |
| Actavis Group PTC ehf | 392 |
2 |
| Daicel Corporation | 2523 |
2 |
| Green Cross Corporation | 219 |
2 |
| Kanata Chemical Technologies Inc. | 11 |
2 |
| Reviva Pharmaceuticals, Inc. | 50 |
2 |
| Yuhan Corporation | 241 |
2 |
| Sandoz AG | 1412 |
1 |
| Merck Patent GmbH | 5728 |
1 |
| Bayer AG | 3501 |
1 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 308 |
1 |
| Kaneka Corporation | 4703 |
1 |
| Cadila Healthcare Limited | 291 |
1 |
| Covestro Deutschland AG | 2833 |
1 |
| Endura S.p.A. | 29 |
1 |
| Georgetown University | 628 |
1 |
| Hanwha Chemical Corporation | 309 |
1 |
| Ind-Swift Laboratories Limited | 49 |
1 |
| Other owners | 11 |